Igor Dolgalev
Impact in
- Ophthalmology top 1%
- Ocular Oncology and Treatments
- Oncology top 2%
- Cutaneous Melanoma Detection and Management
- Cancer Cells and Metastasis
Papers in
- Immunology 13
- Immune Cell Function and Interaction 6
- Immune cells in cancer 4
- Aging 1
- Co-authors
- Adriana HeguyKlaus GriewankMichael R. SpeicherMert SozenMichelle B. CrosbyCatherine D. Van RaamsdonkBoris C. BastianNancy Bouvier
- Journals
- PLoS ONE (3 papers)Blood (3 papers)The International Journal of Spine Surgery (2 papers)Nature Communications (2 papers)Journal of Clinical Investigation (2 papers)
- Partner nations
- United StatesCanadaDenmark
In The Last Decade
Igor Dolgalev
53 papers receiving 3.1k citations
Hit Papers
Peers
Comparison fields: 5 of 108
- Ophthalmology 623
- Oncology 1.1k
- Immunology 637
- Cancer Research 420
- Molecular Biology 1.7k
Countries citing papers authored by Igor Dolgalev
This map shows the geographic impact of Igor Dolgalev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Igor Dolgalev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Igor Dolgalev more than expected).
Fields of papers citing papers by Igor Dolgalev
This network shows the impact of papers produced by Igor Dolgalev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Igor Dolgalev. The network helps show where Igor Dolgalev may publish in the future.
Co-authors
The 25 scholars most cited alongside Igor Dolgalev, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 3 | |
| 3 | 2023 | 18 | |
| 4 | 2023 | 39 | |
| 5 | 2023 | 9 | |
| 6 | 2022 | 21 | |
| 7 | 2022 | 24 | |
| 8 | 2021 | 9 | |
| 9 | 2021 | 25 | |
| 10 | 2020 | 61 | |
| 11 | 2020 | 17 | |
| 12 | 2020 | 66 | |
| 13 | 2019 | 150 | |
| 14 | 2019 | 19 | |
| 15 | 2019 | 45 | |
| 16 | 2017 | 50 | |
| 17 | 2016 | 54 | |
| 18 | 2016 | 11 | |
| 19 | 2015 | 21 | |
| 20 | 2014 | 229 |
About Igor Dolgalev
Igor Dolgalev is a scholar working on Immunology, Aging, Oncology, Pathology and Forensic Medicine and Hematology, having authored 55 papers that have together received 3.2k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (6 papers), Immune Cell Function and Interaction (6 papers), Single-cell and spatial transcriptomics (4 papers), Histone Deacetylase Inhibitors Research (4 papers), Cancer Immunotherapy and Biomarkers (4 papers), Immune cells in cancer (4 papers), Melanoma and MAPK Pathways (3 papers) and Pancreatic and Hepatic Oncology Research (3 papers). The work is most often cited by research in Ophthalmology (623 citations), Oncology (1.1k citations), Immunology (637 citations), Cancer Research (420 citations) and Molecular Biology (1.7k citations). Igor Dolgalev has collaborated with scholars based in United States, Canada and Denmark. Frequent co-authors include Adriana Heguy, Klaus Griewank, Michael R. Speicher, Mert Sozen, Michelle B. Crosby, Catherine D. Van Raamsdonk, Boris C. Bastian, Nancy Bouvier, Thomas Wiesner and Swapna S. Vemula. Their work appears in journals such as PLoS ONE, Blood, The International Journal of Spine Surgery, Nature Communications and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.